Transplantation Drug Development Pipeline Review, 2017

“The Report Transplantation Drug Development Pipeline Review, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

About  Transplantation Drug Market

This report provides an overview of the transplantation pipeline landscape, specifically covering drugs used to prevent and treat organ rejection and graft-versus-host disease. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for graft-versus-host disease (GVHD), and the rejection of bone, liver, kidney, lung and heart transplants.

Get Sample copy of this Report @

Transplant rejection is a complication that can occur after the replacement of a defective host organ with a foreign donor organ. General risks associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Additionally, following a transplant, the immune system may consider the transplanted heart as foreign and mount a response against it, especially if the antigens expressed by the tissues in each do not match. Generally, immunosuppressive drugs are administered simultaneously with the transplant in order to minimize this risk. These immunosuppressive drugs prevent the body from either identifying or attacking the foreign organ via various immune responses thus blocking organ rejection and facilitating a successful transplant.

The size of these pipelines ranges from seven products in heart transplantation to 121 in bone marrow transplantation. A wide range of targets, including integrins, chemokine receptors, protein kinases and cadherins are being developed, with no particular class of target predominating in terms of pipeline volume within each indication. However, there is a clear trend towards immune system molecular targets being studied, reflecting the underlying immune-based pathophysiology of these indications.


– Which companies are the most active within the pipeline for transplantation therapeutics?

– Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?

– To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?

– What are the most important R&D milestones and data publications to have happened in the field of transplantation therapeutics?

View Sample PDF @

Reasons to buy

– Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication

– Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each

– Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these

– Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration.

View Report @

Table of Contents

GBI Research Report Guidance 2

Executive Summary 3

Table of Contents 4

List of Tables 6

List of Figures 12

Introduction 14

Transplantation Report Coverage 14

Bone Marrow Transplant Rejection – Overview 14

Graft Versus Host Disease (GVHD) – Overview 14

Liver Transplant Rejection – Overview 14

Kidney Transplant Rejection – Overview 14

Lung Transplant Rejection – Overview 14

Heart Transplant Rejection – Overview 15

Therapeutics Development 16

Bone Marrow Transplant Rejection 16

Graft Versus Host Disease (GVHD) 27

Liver Transplant Rejection 38

Kidney Transplant Rejection 42

Lung Transplant Rejection 48

Heart Transplant Rejection 51

Therapeutics Assessment 52

Bone Marrow Transplant Rejection 52

Graft Versus Host Disease (GVHD) 62

Liver Transplant Rejection 72

Kidney Transplant Rejection 80

Lung Transplant Rejection 88

Heart Transplant Rejection 96

Companies Involved in Therapeutics Development 104

Bone Marrow Transplant Rejection 104

Graft Versus Host Disease (GVHD) 139

Liver Transplant Rejection 170

Kidney Transplant Rejection 173

Lung Transplant Rejection 185

Heart Transplant Rejection 187

Dormant Projects 189

Bone Marrow Transplant Rejection 189

Graft Versus Host Disease (GVHD) 192

Liver Transplant Rejection 195

Kidney Transplant Rejection 196

Lung Transplant Rejection 198

Heart Transplant Rejection 198

Discontinued Products 199

Bone Marrow Transplant Rejection 199

Graft Versus Host Disease (GVHD) 199

Liver Transplant Rejection 200

Kidney Transplant Rejection 200

Send An Enquiry Request @

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074



Designed by
Powered by
%d bloggers like this: